CA2059510C - Use of nadh and nadph as energy substitutes - Google Patents

Use of nadh and nadph as energy substitutes

Info

Publication number
CA2059510C
CA2059510C CA002059510A CA2059510A CA2059510C CA 2059510 C CA2059510 C CA 2059510C CA 002059510 A CA002059510 A CA 002059510A CA 2059510 A CA2059510 A CA 2059510A CA 2059510 C CA2059510 C CA 2059510C
Authority
CA
Canada
Prior art keywords
nadh
nadph
adenine
nicotinamide
reduced form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002059510A
Other languages
English (en)
French (fr)
Other versions
CA2059510A1 (en
Inventor
Jorg Birkmayer
Walther Birkmayer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2059510A1 publication Critical patent/CA2059510A1/en
Application granted granted Critical
Publication of CA2059510C publication Critical patent/CA2059510C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/153—Nucleic acids; Hydrolysis products or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Mycology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Detergent Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Dental Preparations (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002059510A 1991-01-24 1992-01-16 Use of nadh and nadph as energy substitutes Expired - Fee Related CA2059510C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4102240.8 1991-01-24
DE4102240A DE4102240C1 (enExample) 1991-01-24 1991-01-24

Publications (2)

Publication Number Publication Date
CA2059510A1 CA2059510A1 (en) 1992-07-25
CA2059510C true CA2059510C (en) 1997-06-10

Family

ID=6423720

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002059510A Expired - Fee Related CA2059510C (en) 1991-01-24 1992-01-16 Use of nadh and nadph as energy substitutes

Country Status (14)

Country Link
EP (1) EP0496479B1 (enExample)
JP (1) JP2533709B2 (enExample)
AT (1) ATE112664T1 (enExample)
AU (1) AU663479B2 (enExample)
BR (1) BR9200207A (enExample)
CA (1) CA2059510C (enExample)
DE (2) DE4102240C1 (enExample)
DK (1) DK0496479T3 (enExample)
ES (1) ES2061313T3 (enExample)
FI (1) FI920323A7 (enExample)
HU (1) HU9200213D0 (enExample)
IE (1) IE69861B1 (enExample)
NO (1) NO304672B1 (enExample)
ZA (1) ZA92275B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2167104A1 (en) * 1995-01-17 1996-07-18 Joerg G.D. Birkmayer Nadh and nadph therapeutic agents for nasal, sublingual, rectal and dermal administration
US5712259A (en) * 1996-04-22 1998-01-27 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
US5668114A (en) * 1996-05-08 1997-09-16 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating hypertension
IT1318565B1 (it) * 2000-06-09 2003-08-27 World Pharma Tech Ltd Integratore alimentare proenergetico a base di nadh octocosanolo evitamina e.
US20040126751A1 (en) * 2002-12-27 2004-07-01 Birkmayer Jorg G.D. Method of prolonging the life-span of living cells using NADH, NADPH and ADP-ribose
DE102008010245B4 (de) * 2008-02-20 2011-02-10 Emag Holding Gmbh Verfahren zum Schleifen wellenförmiger Werkstücke
DE102014103443A1 (de) * 2014-03-13 2015-09-17 Jürgen Ruhlmann Komposition zur Verwendung zur Behandlung von Müdigkeit, Konzentrationsschwäche, Entzugserscheinungen, Kopfschmerzen und Erkältungskrankheiten, insbesondere Leistungsabfall, Kater und Müdigkeit
WO2020021734A1 (ja) * 2018-07-26 2020-01-30 オリジンバイオテクノロジー株式会社 機能性鶏卵及びその生産方法
DE202022000567U1 (de) 2022-03-06 2022-03-16 Penta Phi Eg Liposomale Formulierung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3594475A (en) * 1968-04-24 1971-07-20 Kyowa Hakko Kogyo Kk Method of treating and preventing the side effects of antibiotics
DE3380342D1 (en) * 1982-10-26 1989-09-14 Cta Finanz Ag Device and process for optimising the tissue mass of organs within the genetic fluctuation range in humans and animals
IT1162938B (it) * 1983-08-26 1987-04-01 Dino Spisni Composizione per la cura dei tumori maligni in particolare sugli animali
JPS60126220A (ja) * 1983-12-09 1985-07-05 Otsuka Pharmaceut Factory Inc 核酸成分組成物
ES2007350A6 (es) * 1987-05-29 1989-06-16 Ganadera Union Ind Agro Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
JP2736103B2 (ja) * 1988-03-01 1998-04-02 ヴァルター・ビルクマイヤー パーキンソン症候群の治療用医薬、およびその製造方法
AT397201B (de) * 1988-06-03 1994-02-25 Birkmayer Joerg Ddr Verwendung des enzym-cofaktors nadph zur herstellung eines arzneimittels

Also Published As

Publication number Publication date
NO304672B1 (no) 1999-02-01
FI920323L (fi) 1992-07-25
DK0496479T3 (da) 1995-04-18
JP2533709B2 (ja) 1996-09-11
ES2061313T3 (es) 1994-12-01
JPH05262652A (ja) 1993-10-12
EP0496479A1 (de) 1992-07-29
DE59200603D1 (de) 1994-11-17
EP0496479B1 (de) 1994-10-12
FI920323A7 (fi) 1992-07-25
ZA92275B (en) 1992-12-30
HU9200213D0 (en) 1992-04-28
NO920315D0 (no) 1992-01-23
ATE112664T1 (de) 1994-10-15
NO920315L (no) 1992-07-27
DE4102240C1 (enExample) 1992-04-09
IE920198A1 (en) 1992-07-29
CA2059510A1 (en) 1992-07-25
AU1039292A (en) 1992-07-30
AU663479B2 (en) 1995-10-12
BR9200207A (pt) 1992-10-06
FI920323A0 (fi) 1992-01-24
IE69861B1 (en) 1996-10-16

Similar Documents

Publication Publication Date Title
USRE43029E1 (en) Process for preparing a creatine heterocyclic acid salt and method of use
US5612375A (en) Creatine beverage and producing process thereof
US8518455B2 (en) Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose
US20090104171A1 (en) Metabolic Enhancement Therapy
CA2059510C (en) Use of nadh and nadph as energy substitutes
AU750645B2 (en) Composition comprising L-carnitine or an alkanoyl L-carnitine and NADH and/or NADPH
CA2434482C (en) Food supplement with a slimming effect
AU742460B2 (en) Fatty acids as a diet supplement
AU782479B2 (en) Dietary supplement energy-providing to skeletal muscles and protecting the cardiovascular tract
US20010020007A1 (en) Vitamin preparations for reducing oxygen consumption during physical efforts
Obeid et al. Effect of diet supplementation with glutamine, dihydroxyacetone, and leucine on food intake, weight gain, and postprandial glycogen metabolism of rats
Littman et al. Acceleration of growth of sarcoma 180 with pyridoxamine and retardation with penicillamine.
AU2021104139A4 (en) Nadh composition for improving exercise endurance and use thereof
WO2005089765A1 (en) Enzyme cofactor combination for supplementing pyruvate dehydrogenase and alpha ketogluterate dehydrogenase complexes
CN1151288A (zh) 防治饮酒和肥胖诱发脂肪肝及减肥的营养素及制造方法
MX2007000940A (es) Uso de piruvato de metilo para el proposito de incrementar la produccion de energia muscular.
CZ5849U1 (cs) Speciální přírodní stimulant organizmu
HK1036589A (en) Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph
MXPA00009983A (en) Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed